Report for Yashi Jain(23Y/F)
Tests asked Comprehensive Full Body Checkup With Vitamin D And B12 - New
Test date 10 Feb 2023 Report status Complete Report
Name : YASHI JAIN(23Y/F) ADDRESS :
Ref. By : SELF
242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
Report Availability Summary
Full Report Available
Note : This is summary page. Please refer to the table below for the details
Test Report Status
● COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D AN Available
25-OH VITAMIN D (TOTAL) Available
COMPLETE URINE ANALYSIS Available
FASTING BLOOD SUGAR(GLUCOSE) Available
HbA1c Available
HEMOGRAM - 6 PART (DIFF) Available
IRON Available
KIDPRO Available
LIPID PROFILE Available
LIVER FUNCTION TESTS Available
TOTAL IRON BINDING CAPACITY (TIBC) Available
TOTAL THYROXINE (T4) Available
TOTAL TRIIODOTHYRONINE (T3) Available
TSH - ULTRASENSITIVE Available
UNSAT.IRON-BINDING CAPACITY(UIBC) Available
VITAMIN B-12 Available
Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS
25-OH VITAMIN D (TOTAL) C.L.I.A 5.81 ng/ml
Reference Range :
DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous;
both are critical for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight,
dietary deficiency, nephrotic syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.
Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
Method : FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY
VITAMIN B-12 C.L.I.A 207 pg/ml
Reference Range :
Normal : 211 - 911 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as
meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the
formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis
associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in conjunction with the
patients medical history, clinical examination and other findings.
Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml
Kit Validation reference:
Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV
Mosby; 1987:569–73.
Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
Please correlate with clinical conditions.
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544
Page : 1 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS
IRON PHOTOMETRY < 15 µg/dl
Reference Range :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 437.33 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 3.43 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 422.33 µg/dl
Reference Range :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544
Page : 2 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY 242/143 YAHIYAGANJ NADAN MAHAL ROAD AMBERGANJ
: SELF
LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 65 mg/dl 40-60
HDL / LDL RATIO CALCULATED 0.83 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 79 mg/dl < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.3 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.53 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 100 mg/dl < 150
LDL / HDL RATIO CALCULATED 1.2 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 82.34 mg/dl < 160
VLDL CHOLESTEROL CALCULATED 19.99 mg/dl 5 - 40
Please correlate with clinical conditions.
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
HD/LD - Derived from HDL and LDL values.
LDL - DIRECT MEASURE
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
TRI/H - Derived from TRIG and HDL Values
TRIG - ENZYMATIC, END POINT
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544
Page : 3 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY 242/143 YAHIYAGANJ NADAN MAHAL ROAD AMBERGANJ
: SELF
LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
ALKALINE PHOSPHATASE PHOTOMETRY 86.06 U/L 45 - 129
BILIRUBIN - TOTAL PHOTOMETRY 0.66 mg/dl 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.21 mg/dl < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.45 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.53 U/l < 38
SGOT / SGPT RATIO CALCULATED 1.07 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 18.79 U/l < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 17.48 U/l < 34
PROTEIN - TOTAL PHOTOMETRY 7.48 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.59 gm/dl 3.2-4.8
SERUM GLOBULIN CALCULATED 2.89 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.59 Ratio 0.9 - 2
Please correlate with clinical conditions.
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544
Page : 4 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY 242/143 YAHIYAGANJ NADAN MAHAL ROAD AMBERGANJ
: SELF
LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
UREA (CALCULATED) CALCULATED 13.63 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 6.37 mg/dl 7 - 25
UREA / SR.CREATININE RATIO CALCULATED 26.73 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.51 mg/dl 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 12.49 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.84 mg/dl 8.8-10.6
URIC ACID PHOTOMETRY 3.13 mg/dl 3.2 - 6.1
Please correlate with clinical conditions.
Method :
UREAC - Derived from BUN Value.
BUN - KINETIC UV ASSAY.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544
Page : 5 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
242/143 YAHIYAGANJ NADAN MAHAL ROAD AMBERGANJ
REF. BY : SELF
LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN
D AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 120 ng/dl 60-200
TOTAL THYROXINE (T4) C.L.I.A 9.6 µg/dl 4.5-12
TSH - ULTRASENSITIVE E.C.L.I.A 2.13 µIU/ml 0.54-5.30
Comments : ***
Please correlate with clinical conditions.
Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor
reclassified as Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones
in Indian women with normal pregnancy : New light through old window. Indian Journal of Contemporary
medical research. 2019; 6(4)
Disclaimer :
Results should always be interpreted using the reference range provided by the laboratory that performed the test.
Different laboratories do tests using different technologies , methods and using different reagents which may cause difference
In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544 Page : 6 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN
D AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 136 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.
Please correlate with clinical conditions.
Method:- CKD-EPI Creatinine Equation
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:19
Report Released on (RRT) : 10 Feb 2023 19:32
Sample Type : SERUM
Labcode : 1002084410/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AN848544 Page : 7 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5 %
Reference Range :
Reference Range: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control
5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C. using Biorad Variant II Turbo
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 97 mg/dl
Reference Range :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:04
Report Released on (RRT) : 10 Feb 2023 16:54
Sample Type : EDTA
Labcode : 1002082655/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AP361851
Page : 8 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D
AND B12 - NEW
TEST NAME VALUE UNITS REFERENCE RANGE
TOTAL LEUCOCYTES COUNT (WBC) 10.04 X 10³ / µL 4.0-10.0
NEUTROPHILS 66.6 % 40-80
LYMPHOCYTE PERCENTAGE 27.9 % 20.0-40.0
MONOCYTES 3.2 % 0.0-10.0
EOSINOPHILS 1.8 % 0.0-6.0
BASOPHILS 0.2 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT 6.69 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 2.8 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.32 X 10³ / µL 0.2-1.0
BASOPHILS - ABSOLUTE COUNT 0.02 X 10³ / µL 0.02-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.18 X 10³ / µL 0.02-0.5
IMMATURE GRANULOCYTES(IG) 0.03 X 10³ / µL 0.0-0.3
TOTAL RBC 5.17 X 10^6/µL 3.9-4.8
NUCLEATED RED BLOOD CELLS Nil X 10³ / µL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 9.9 g/dL 12.0-15.0
HEMATOCRIT(PCV) 34.9 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) 67.5 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.1 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 28.4 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 40.8 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 17.2 % 11.6-14.0
PLATELET DISTRIBUTION WIDTH(PDW) 10.6 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 10 fL 6.5-12
PLATELET COUNT 458 X 10³ / µL 150-400
PLATELET TO LARGE CELL RATIO(PLCR) 25.7 % 19.7-42.4
PLATELETCRIT(PCT) 0.46 % 0.19-0.39
Remarks : Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly microcytic hypochromic cells with ovalocytes &
elliptocytes. Platelets:Appear adequate in smear.
Please Correlate with clinical conditions.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow
Cytometry Method (using a semiconductor laser), and SLS- hemoglobin method)
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:04
Report Released on (RRT) : 10 Feb 2023 16:54
Sample Type : EDTA
Labcode : 1002082655/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AP361851 Page : 9 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN AMBERGANJ LUCKNOW
D AND B12 - NEW
TEST NAME OBSERVATION UNITS REFERENCE RANGE
COMPLETE URINOGRAM
VOLUME 3 mL -
COLOUR PALE YELLOW - Pale Yellow
APPEARANCE CLEAR - Clear
SPECIFIC GRAVITY 1.01 - 1.003-1.030
PH 6 - 5-8
URINARY PROTEIN ABSENT mg/dl Absent
URINARY GLUCOSE ABSENT mg/dl Absent
URINE KETONE ABSENT mg/dl Absent
URINARY BILIRUBIN ABSENT mg/dl Absent
UROBILINOGEN < 0.2 mg/dl <=0.2
BILE SALT ABSENT - Absent
BILE PIGMENT ABSENT - Absent
URINE BLOOD ABSENT Cells/ul* Absent
NITRITE ABSENT - Absent
MICROALBUMIN 10 mg/l < 20
MUCUS ABSENT - Absent
RED BLOOD CELLS ABSENT Cells/ul* Absent
URINARY LEUCOCYTES (PUS CELLS) ABSENT Cells/ul* Absent
EPITHELIAL CELLS 6-7 - 0-4
CASTS ABSENT - Absent
CRYSTALS ABSENT - Absent
BACTERIA ABSENT - Absent
YEAST ABSENT - Absent
PARASITE ABSENT - Absent
* To Obtain Counts in Cells / HPF Divide the Cells / ul by 5
Please correlate with clinical conditions.
Method : Fully Automated FUS3000-5 Urinalysis Dipstick Method, Microscopy
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:06
Report Released on (RRT) : 10 Feb 2023 16:58
Sample Type : URINE
Dr Nidhi Gupta MD (Path)
Labcode : 1002082863/DG007
Barcode : AP610300 Page : 10 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
NAME : YASHI JAIN(23Y/F) HOME COLLECTION :
REF. BY : SELF 242/143 YAHIYAGANJ NADAN MAHAL ROAD
AMBERGANJ LUCKNOW
TEST ASKED : COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN
D AND B12 - NEW
TEST NAME TECHNOLOGY VALUE UNITS
FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 89.71 mg/dL
Reference Range :-
As per ADA Guideline: Fasting Plasma Glucose (FPG)
Normal 70 to 100 mg/dl
Prediabetes 100 mg/dl to 125 mg/dl
Diabetes 126 mg/dl or higher
Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD
~~ End of report ~~
Sample Collected on (SCT) : 10 Feb 2023 12:57
Sample Received on (SRT) : 10 Feb 2023 15:17
Report Released on (RRT) : 10 Feb 2023 16:28
Sample Type : FLUORIDE
Labcode : 1002084213/DG007 Dr Nidhi Gupta MD (Path)
Barcode : AR194221 Page : 11 of 11
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd